Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Haploinsufficiency in tumor predisposition syndromes: altered genomic transcription in morphologically normal cells heterozygous for VHL or TSC mutation.

Peri S, Caretti E, Tricarico R, Devarajan K, Cheung M, Sementino E, Menges CW, Nicolas E, Vanderveer LA, Howard S, Conrad P, Crowell JA, Campbell KS, Ross EA, Godwin AK, Yeung AT, Clapper ML, Uzzo RG, Henske EP, Ricketts CJ, Vocke CD, Linehan WM, Testa JR, Bellacosa A, Kopelovich L, Knudson AG.

Oncotarget. 2017 Mar 14;8(11):17628-17642. doi: 10.18632/oncotarget.12192.

2.

Inflammation-Related IL1β/IL1R Signaling Promotes the Development of Asbestos-Induced Malignant Mesothelioma.

Kadariya Y, Menges CW, Talarchek J, Cai KQ, Klein-Szanto AJ, Pietrofesa RA, Christofidou-Solomidou M, Cheung M, Mossman BT, Shukla A, Testa JR.

Cancer Prev Res (Phila). 2016 May;9(5):406-414. doi: 10.1158/1940-6207.CAPR-15-0347. Epub 2016 Mar 2.

3.

Bap1 Is a Bona Fide Tumor Suppressor: Genetic Evidence from Mouse Models Carrying Heterozygous Germline Bap1 Mutations.

Kadariya Y, Cheung M, Xu J, Pei J, Sementino E, Menges CW, Cai KQ, Rauscher FJ, Klein-Szanto AJ, Testa JR.

Cancer Res. 2016 May 1;76(9):2836-44. doi: 10.1158/0008-5472.CAN-15-3371. Epub 2016 Feb 19.

4.

Flaxseed lignans enriched in secoisolariciresinol diglucoside prevent acute asbestos-induced peritoneal inflammation in mice.

Pietrofesa RA, Velalopoulou A, Arguiri E, Menges CW, Testa JR, Hwang WT, Albelda SM, Christofidou-Solomidou M.

Carcinogenesis. 2016 Feb;37(2):177-87. doi: 10.1093/carcin/bgv174. Epub 2015 Dec 17.

5.

Genomic Copy Number Alterations in Renal Cell Carcinoma with Sarcomatoid Features.

Ito T, Pei J, Dulaimi E, Menges C, Abbosh PH, Smaldone MC, Chen DY, Greenberg RE, Kutikov A, Viterbo R, Uzzo RG, Testa JR.

J Urol. 2016 Apr;195(4 Pt 1):852-8. doi: 10.1016/j.juro.2015.10.180. Epub 2015 Nov 18.

6.

Germline mutation of Bap1 accelerates development of asbestos-induced malignant mesothelioma.

Xu J, Kadariya Y, Cheung M, Pei J, Talarchek J, Sementino E, Tan Y, Menges CW, Cai KQ, Litwin S, Peng H, Karar J, Rauscher FJ, Testa JR.

Cancer Res. 2014 Aug 15;74(16):4388-97. doi: 10.1158/0008-5472.CAN-14-1328. Epub 2014 Jun 13.

7.

Merlin deficiency predicts FAK inhibitor sensitivity: a synthetic lethal relationship.

Shapiro IM, Kolev VN, Vidal CM, Kadariya Y, Ring JE, Wright Q, Weaver DT, Menges C, Padval M, McClatchey AI, Xu Q, Testa JR, Pachter JA.

Sci Transl Med. 2014 May 21;6(237):237ra68. doi: 10.1126/scitranslmed.3008639.

8.

Tumor suppressor alterations cooperate to drive aggressive mesotheliomas with enriched cancer stem cells via a p53-miR-34a-c-Met axis.

Menges CW, Kadariya Y, Altomare D, Talarchek J, Neumann-Domer E, Wu Y, Xiao GH, Shapiro IM, Kolev VN, Pachter JA, Klein-Szanto AJ, Testa JR.

Cancer Res. 2014 Feb 15;74(4):1261-1271. doi: 10.1158/0008-5472.CAN-13-2062. Epub 2013 Dec 26.

9.

STED nanoscopy combined with optical tweezers reveals protein dynamics on densely covered DNA.

Heller I, Sitters G, Broekmans OD, Farge G, Menges C, Wende W, Hell SW, Peterman EJ, Wuite GJ.

Nat Methods. 2013 Sep;10(9):910-6. doi: 10.1038/nmeth.2599. Epub 2013 Aug 11.

PMID:
23934077
10.

Group I p21-activated kinases (PAKs) promote tumor cell proliferation and survival through the AKT1 and Raf-MAPK pathways.

Menges CW, Sementino E, Talarchek J, Xu J, Chernoff J, Peterson JR, Testa JR.

Mol Cancer Res. 2012 Sep;10(9):1178-88. Epub 2012 Jul 12.

11.

Regulation of epithelial differentiation and proliferation by the stroma: a role for the retinoblastoma protein.

Pickard A, Cichon AC, Menges C, Patel D, McCance DJ.

J Invest Dermatol. 2012 Dec;132(12):2691-9. doi: 10.1038/jid.2012.201. Epub 2012 Jun 14.

12.

The rotation-coupled sliding of EcoRV.

Dikić J, Menges C, Clarke S, Kokkinidis M, Pingoud A, Wende W, Desbiolles P.

Nucleic Acids Res. 2012 May;40(9):4064-70. doi: 10.1093/nar/gkr1309. Epub 2012 Jan 12.

13.

Losses of both products of the Cdkn2a/Arf locus contribute to asbestos-induced mesothelioma development and cooperate to accelerate tumorigenesis.

Altomare DA, Menges CW, Xu J, Pei J, Zhang L, Tadevosyan A, Neumann-Domer E, Liu Z, Carbone M, Chudoba I, Klein-Szanto AJ, Testa JR.

PLoS One. 2011 Apr 19;6(4):e18828. doi: 10.1371/journal.pone.0018828.

14.

Upregulation of DLX5 promotes ovarian cancer cell proliferation by enhancing IRS-2-AKT signaling.

Tan Y, Cheung M, Pei J, Menges CW, Godwin AK, Testa JR.

Cancer Res. 2010 Nov 15;70(22):9197-206. doi: 10.1158/0008-5472.CAN-10-1568. Epub 2010 Nov 2.

15.

A Phosphotyrosine Proteomic Screen Identifies Multiple Tyrosine Kinase Signaling Pathways Aberrantly Activated in Malignant Mesothelioma.

Menges CW, Chen Y, Mossman BT, Chernoff J, Yeung AT, Testa JR.

Genes Cancer. 2010 May 1;1(5):493-505.

16.

Human papillomavirus type 16 E6/E7 upregulation of nucleophosmin is important for proliferation and inhibition of differentiation.

McCloskey R, Menges C, Friedman A, Patel D, McCance DJ.

J Virol. 2010 May;84(10):5131-9. doi: 10.1128/JVI.01965-09. Epub 2010 Mar 17.

17.

FAS-associated factor 1 (FAF1): diverse functions and implications for oncogenesis.

Menges CW, Altomare DA, Testa JR.

Cell Cycle. 2009 Aug 15;8(16):2528-34. Epub 2009 Aug 16. Review.

18.

Activated TNF-alpha/NF-kappaB signaling via down-regulation of Fas-associated factor 1 in asbestos-induced mesotheliomas from Arf knockout mice.

Altomare DA, Menges CW, Pei J, Zhang L, Skele-Stump KL, Carbone M, Kane AB, Testa JR.

Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3420-5. doi: 10.1073/pnas.0808816106. Epub 2009 Feb 17.

19.
20.

Human papillomavirus type 16 E7 up-regulates AKT activity through the retinoblastoma protein.

Menges CW, Baglia LA, Lapoint R, McCance DJ.

Cancer Res. 2006 Jun 1;66(11):5555-9.

21.

AKT1 provides an essential survival signal required for differentiation and stratification of primary human keratinocytes.

Thrash BR, Menges CW, Pierce RH, McCance DJ.

J Biol Chem. 2006 Apr 28;281(17):12155-62. Epub 2006 Mar 3.

22.

[Therapeutic experiences with alcohol-related Korsakoff syndrome].

Mrazek M, Menges C, Steffes J, Thelen B, Erkwoh R.

Nervenarzt. 1999 Sep;70(9):790-4. German.

PMID:
10522246
23.

[Severe "late" dystonia after neuroleptic anxiolysis with fluspirilene].

Kappler J, Menges C, Ferbert A, Ebel H.

Nervenarzt. 1994 Jan;65(1):66-8. German.

PMID:
8145878
24.

[Multiple sclerosis and subcortical arteriosclerotic encephalopathy as clinical differential diagnosis].

Weiller C, Menges C, Seiler U.

Nervenarzt. 1992 Dec;63(12):746-50. German. No abstract available.

PMID:
1494389
25.

Splenectomy for hypersplenism.

FERRIS DO, HARGRAVES MM, MENGES CG.

Surg Clin North Am. 1957 Aug;37(4):1119-82. No abstract available.

PMID:
13455427
26.

ON EINSTEIN'S THEORY OF RELATIVITY.

Menges CL.

Science. 1926 Apr 23;63(1634):427-8. No abstract available.

PMID:
17749340

Supplemental Content

Loading ...
Support Center